Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03272685 · ClinicalTrials.gov registry record · Phase 3
Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace
A Phase 3 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 3
- Development phase
- 799
- Enrollment target
NCT03272685 is a Phase 3 study that has completed, run by University of Minnesota. The registered enrollment target is 799 participants.
The verdict
NCT03272685, a Phase 3 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 799 participants
- Enrollment target
Study Summary
This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine content (NNC) cigarettes.
Interventions
- DRUG Very Low Nicotine Content Cigarettes
- DRUG Normal Nicotine Content Cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 799 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-01-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03272685
The ClinicalTrials.gov registry entry for NCT03272685 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 799 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Very Low Nicotine Content Cigarettes is the first listed.
NCT03272685 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03272685 about?
NCT03272685 is a clinical study titled "Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace". This project will examine the impact of very low nicotine content (VLNC) cigarettes in a complex tobacco and nicotine product marketplace. We will compare the number of cigarettes smoked and cigarette-free days in an experimental marketplace that contains VLNC cigarettes versus normal nicotine conte...
What is the current status of trial NCT03272685?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 799 participants. The study started on 2018-06-01. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT03272685?
The interventions under investigation include: Very Low Nicotine Content Cigarettes (DRUG), Normal Nicotine Content Cigarettes (DRUG).
Who is sponsoring clinical trial NCT03272685?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.